Healthcare (SH:603313) Tong Hua Shun Cai Bao·2025-04-25 11:00Financial Performance - The company reported a basic earnings per share of -0.2700 yuan for 2024, a decrease of 222.73% compared to 0.2200 yuan in 2023 [1] - The net profit for 2024 was -1.51 billion yuan, a decline of 241.12% from 1.07 billion yuan in 2023 [1] - The return on equity (ROE) for 2024 was -3.99%, down from 3.41% in 2023, indicating a significant deterioration in profitability [1] - Total revenue for 2024 was 84.49 billion yuan, representing a 5.93% increase from 79.76 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 31,884.45 million shares, accounting for 55.88% of the circulating shares, with a change of 836,400 shares from the previous period [2] - The largest shareholder, 倪张根, holds 19,383.12 million shares, representing 33.97% of the total share capital, with no change in holdings [3] - New entrants among the top shareholders include 交银瑞思混合(LOF) and 湖南长心私募基金管理有限公司, while several previous shareholders have exited the top ten list [3] Dividend Policy - The company has announced no distribution or capital increase for the current period [4]